EcoDrugPlus

Ensembl ID : ENSMPUG00000000801
Gene Symbol: RPL17
1 Cross references
121 Possible Orthologues:

Ensembl ID : ENSMPUG00000005294
Gene Symbol: RPS4X
1 Cross references
184 Possible Orthologues:

Ensembl ID : ENSMPUG00000006166
Gene Symbol: RPL36
1 Cross references
205 Possible Orthologues:

Ensembl ID : ENSMPUG00000013776
Gene Symbol: RPS14
1 Cross references
246 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSMPUG00000007095
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSMPUG00000005662
Gene Symbol: HMGCR
2 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSMPUG00000015308
Gene Symbol: PDPK1
2 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSMPUG00000002050
Gene Symbol: HPD
2 Cross references
204 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSMPUG00000005337
Gene Symbol: NT5E
2 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSMPUG00000020078
Gene Symbol: HTR1A
2 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSMPUG00000018381
Gene Symbol: HTR1B
2 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSMPUG00000018659
Gene Symbol: HTR1E
2 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).